Zobrazeno 1 - 10
of 74
pro vyhledávání: '"S Erdes"'
Autor:
E. M. Agafonova, S. Erdes
Publikováno v:
Rheumatology Science and Practice. 60:587-593
Coxitis is one of the most common causes of early disability in patients with axial spondyloarthritis (axSpA), but the therapy for this condition has not been developed.Goal. to assess the effect of different treatment regimens on the manifestations
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E. Agafonova, S. Erdes
Publikováno v:
Annals of the Rheumatic Diseases. 81:798.3-799
BackgroundAlmost half of the patients with axial spondyloarthritis (axSpA) in Russia diagnosed hip joint lesions (HJ), but the causes and rates of progression are not studied. Until now, it remains unclear whether synovitis detected on MRI and ultras
Publikováno v:
Annals of the Rheumatic Diseases. 81:1509.1-1509
BackgroundThe main goal of “T2T” strategy for spondyloarthritis (SpA) is to achieve clinical remission or inactive disease. In 2001, the ASAS formulated criteria for partial remission [1], and the Russian Expert Group for Study of SpA (ExSpA) in
Publikováno v:
Annals of the Rheumatic Diseases. 81:1510.1-1510
BackgroundThe main goal of “T2T” strategy for spondyloarthritis (SpA) is to achieve clinical remission or inactive disease. In 2001, the ASAS formulated criteria for partial remission [1], and the Russian Expert Group for Study of SpA (ExSpA) in
Publikováno v:
Annals of the Rheumatic Diseases. 81:1514.2-1515
BackgroundDespite the availability of newest guidelines for the treatment of ankylosing spondylitis and various groups of genetically engineered biological drugs, there are still patients with refractory, i.e., resistant to therapy (with two or more
Publikováno v:
Annals of the Rheumatic Diseases. 81:1504.1-1504
BackgroundAlmost half of the patients with axial spondyloarthritis (axSpA) in Russia diagnosed hip joint lesions (HJ), but the causes and rates of progression are not studied. Until now, it remains unclear whether synovitis detected on MRI and ultras
Autor:
S. Erdes, E. Agafonova
Publikováno v:
Annals of the Rheumatic Diseases. 80:337.2-337
Background:Standard therapy for axial spondyloarthritis (axSpA) is effective in inflammatory lesions of the axial skeleton and peripheral arthritis, but its effect on coxitis has not been studied.Objectives:To assess the effectiveness of anti-TNF the
Publikováno v:
Annals of the Rheumatic Diseases. 80:1261.1-1261
Background:Therapy with interleukin 17 (iIL17) inhibitors in Russia is indicated for patients with ankylosing spondylitis (AS) or psoriatic arthritis (PSA). If standard therapy is ineffective in these diseases, both tumor necrosis factor inhibitors (
Publikováno v:
Annals of the Rheumatic Diseases. 80:1040.1-1040
Background:Ankylosing spondylitis is a chronic systemic inflammatory disease. Inflammation and high levels of serum amyloid A (SAA) protein are predisposing factors for secondary AA amyloidosis. The role of SAA1 gene polymorphisms in AS is not well u